#AI

Microsoft faces Wall Street scrutiny over its AI strategy amidst market volatility. Despite stock declines and competition for its Copilot AI, the company’s Azure cloud platform shows strong growth. Analysts are divided on the stock’s prospects, with some citing fundamental strengths and others highlighting challenges in AI adoption and operational costs. Recent organizational changes aim to boost AI development.

Oracle is reportedly laying off thousands of employees as it invests heavily in AI infrastructure. The company’s stock has underperformed, facing scrutiny over its debt financing for AI and dwindling cash flow. Despite challenges, Oracle sees strong demand for AI infrastructure, reflected in its substantial remaining performance obligations.

Activist investor Irenic Capital Management has urged Snap CEO Evan Spiegel to implement strategic changes to significantly boost the company’s stock. Recommendations include potentially shutting down or divesting the AR glasses unit and reducing the workforce by 1,000 employees, leveraging AI for operational streamlining. Irenic believes these steps could increase Snap’s stock by nearly 600%. Snap stated it welcomes shareholder input and is evaluating actions for long-term value.

Nvidia is investing $2 billion in Marvell Technology, boosting Marvell’s shares and signaling accelerating AI demand. The partnership aims to enhance Marvell’s integration into Nvidia’s AI infrastructure, leveraging combined expertise in silicon photonics and AI-centric telecommunications. This move expands Nvidia’s AI ecosystem, supporting custom ASICs and strengthening its market position in the booming AI sector.

Micron’s stock plunged 10%, extending a 30% post-earnings sell-off despite exceeding expectations. The decline mirrors a broader tech market downturn influenced by geopolitical tensions. While Micron’s AI chip demand is strong, supply constraints limit customer orders to 50-66% of needs. Despite significant year-over-year growth, recent volatility has tempered its year-to-date performance, highlighting the AI market’s inherent risks and the importance of scaling production.

Financial institutions are now strategically adopting AI, moving beyond mere efficiency to address stringent regulations and capitalize on revenue growth. Generative AI and neural networks demand secure, ethical AI deployment with robust oversight and industry-specific legislation. Proper algorithmic oversight, exemplified in lending, requires explainability to avoid severe legal ramifications. Investing in ethical AI and data maturity, including metadata management and data lineage tracking, is crucial for speed to market and sustained revenue. Security teams must defend mathematical integrity against adversarial attacks and implement zero-trust architectures. Dismantling the engineering and compliance divide through cross-functional collaboration is key. While vendor solutions offer convenience, retaining control through open standards and interoperability is essential for long-term success.

Glia, a customer service platform specializing in AI for banking, won the Banking and Financial Services Category at the 2026 Artificial Intelligence Excellence Awards. The recognition highlights Glia’s practical AI solutions that automate up to 80% of customer interactions, freeing up human agents for higher-value tasks. Their platform is designed to navigate security and regulatory complexities of generative AI, and Glia offers contractual guarantees against AI hallucinations and prompt injection vulnerabilities, ensuring AI safety and security for financial institutions.

Eli Lilly has acquired rights to Insilico Medicine’s AI-discovered drug pipeline in a $2.75 billion deal. This significant partnership highlights AI’s growing role in drug discovery. The agreement includes an upfront payment and future royalties, reflecting the innovative nature of the collaboration. Insilico, a leader in AI-driven drug discovery, has numerous candidates in clinical trials. This deal leverages Lilly’s expertise with Insilico’s AI platform, aiming to accelerate the development of new therapies and reinforce Lilly’s expansion into the Chinese market.

Meta’s $2 billion acquisition of AI startup Manus, with Chinese roots, has triggered a regulatory review by Beijing. This move signals China’s intent to curb talent and business exodus, scrutinizing the “Singapore washing” model previously used to navigate U.S.-China tech tensions. The review, including founder travel restrictions, casts doubt on offshore structuring viability, forcing founders to re-evaluate strategies amidst escalating tech rivalry.

A Jeffrey Epstein survivor has filed a class-action lawsuit against the Trump administration and Google, alleging wrongful disclosure of victim information by the Justice Department and its subsequent republication by Google’s AI. The suit challenges Section 230 protections, arguing AI’s role in disseminating sensitive data causes renewed trauma and harassment. This action coincides with other AI-related scrutiny of Google and raises questions about platform accountability and potential legislative changes to Section 230.